Home › Stocks › BBLGW

BBLGW — BONE BIOLOGICS CORP

Reported value held$117.18K
Funds holding (latest)5
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)2
Institutional value$71.44K · 18.80K sh
New / Add / Cut / Exit0 / 1 / 1 / 0 · Updated 2026-11-17
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Reducing -30.1% (-8.11K sh)
Institutional value change Down -82.1%

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 2 SEC-registered investment managers reported holding BBLGW (BONE BIOLOGICS CORP) in their latest 13F filings, with a combined reported value of $71.44K across 18.80K shares. That is -30.1% by share count (-8.11K shares) versus the previous quarter, while reported value moved -82.1%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 1 added to existing stakes, 1 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of BONE BIOLOGICS CORP (BBLGW) include Citadel Advisors, Marex Group Ltd, UBS Group AG, ranked by reported 13F value among the 5 institutional holders on this page.

BBLGW is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 2 18.80K $71.44K -30.1%
Q2 2026 2 26.91K $400.07K -10.8%
Q1 2026 2 30.17K $689.92K -15.3%
Q4 2025 2 35.62K $550.51K -0.3%
Q3 2025 3 35.82K $357.67K -0.3%
Q2 2025 3 35.92K $537.04K -0.0%
Q1 2025 3 35.92K $557.31K +2.9%
Q4 2024 2 34.80K $1.48M -5.4%

Over the 8 quarters shown, institutional share counts decreased 46% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (-15.3%).

Top Institutional Holders (Q3 2026) — 2 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 17.90K $68.03K 0.00% Reduce
UBS Group AG 898 $3.41K 0.00% Add

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 2 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 26.40K $395.97K 0.00% Reduce
UBS Group AG 513 $4.10K 0.00% Add

Q1 2026 — 2 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 29.75K $684.30K 0.00% Reduce
UBS Group AG 422 $5.62K 0.00% Add

Q4 2025 — 2 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 35.32K $547.51K 0.00% Reduce
UBS Group AG 300 $3.00K 0.00% Add

Q3 2025 — 3 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 35.57K $355.73K 0.00% Hold
UBS Group AG 143 $1.14K 0.00% Hold
Bank of America Corp 100 $800 0.00% Hold

Q2 2025 — 3 funds

FundSharesValuePortfolio WeightChange
Citadel Advisors 35.67K $535.10K 0.00% Hold
UBS Group AG 143 $1.14K 0.00% Hold
Bank of America Corp 100 $800 0.00% Hold

New Positions (Q3 2026)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 5 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q4 2021
Citadel Advisors 17.90K 26.40K 29.75K 35.32K 35.57K 35.67K 35.68K 34.76K 36.75K 36.76K 33.04K — 24.33K — — — — — —
UBS Group AG 898 513 422 300 143 143 143 40 40 — — — 61 — 250 4.30K 4.30K 10.89K 4.60K
Marex Group Ltd — — — — — — — — — — — 11.46K — — — — — — —
Bank of America Corp — — — — 100 100 100 — — 7 100 — — — — — — — —
JPMorgan Chase & Co — — — — — — — — — — — — 2 2 — — — — —

Download holders (CSV)

FAQ

Which funds hold BBLGW?

As of 2026-Q3, 2 institutional funds reported holding BBLGW (BONE BIOLOGICS CORP) in SEC 13F filings, with a combined reported value of $71.44K.

How many shares of BBLGW do institutions own?

13F filers reported 18.80K shares of BBLGW, worth $71.44K in aggregate at the end of 2026-Q3.

Is institutional ownership of BBLGW rising or falling?

Share counts moved -30.1% versus the prior quarter — distribution.

Who are the top institutional holders of BBLGW?

The largest 13F holders are Citadel Advisors, Marex Group Ltd, UBS Group AG, Bank of America Corp, JPMorgan Chase & Co; the top 25 are ranked at the top of this page.

Who are the major shareholders of BONE BIOLOGICS CORP?

The major shareholders of BONE BIOLOGICS CORP (BBLGW) by reported 13F value are Citadel Advisors, Marex Group Ltd, UBS Group AG, Bank of America Corp, JPMorgan Chase & Co, among 5 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own BBLGW" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/BBLGW/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →